Auxilium Pharmaceuticals Inc (AUXL)

36.47
0.06 0.16
Prev Close 36.53
Open 36.50
Day Low/High 36.08 / 36.76
52 Wk Low/High 17.10 / 37.92
Volume 3.72M
Avg Volume 1.22M
Exchange
Shares Outstanding 51.02M
Market Cap 1.94B
EPS -0.37
Div & Yield N.A. (N.A)

Latest News

Health Care Stocks: A Year in Review and Predictions for 2015

Health Care Stocks: A Year in Review and Predictions for 2015

In 2014 drugmakers long on cash but short on growth bought quick access to markets that would have otherwise taken years to build. Can this continue?

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Auxilium Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Auxilium Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

AUXILIUM PHARMACEUTICALS INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Auxilium Pharmaceuticals Inc. Over The Proposed Sale Of The Company To Endo International PLC -AUXL

AUXILIUM PHARMACEUTICALS INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Auxilium Pharmaceuticals Inc. Over The Proposed Sale Of The Company To Endo International PLC -AUXL

Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Auxilium Pharmaceuticals Inc.

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Auxilium Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

SHAREHOLDER ALERT: Brower Piven Launches An Investigation Into The Proposed Sale Of Auxilium Pharmaceuticals, Inc. And Encourages Investors To Contact The Firm For Additional Information

The securities litigation law firm of Brower Piven, A Professional Corporation, has commenced an investigation into possible breaches of fiduciary duty and other violations of state law by the Board of Directors of...

AUXILIUM PHARMACEUTICALS INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Auxilium Pharmaceuticals Inc. (AUXL) Over The Proposed Sale Of The Company To Endo International PLC (ENDP)

AUXILIUM PHARMACEUTICALS INC. INVESTOR ALERT: Faruqi & Faruqi, LLP Announces The Investigation Of Auxilium Pharmaceuticals Inc. (AUXL) Over The Proposed Sale Of The Company To Endo International PLC (ENDP)

Juan E. Monteverde, a partner at Faruqi & Faruqi, LLP, a leading national securities firm headquartered in New York City, is investigating the Board of Directors of Auxilium Pharmaceuticals Inc.

How Will Endo International (ENDP) Stock Be Affected Today by This Analyst Action?

How Will Endo International (ENDP) Stock Be Affected Today by This Analyst Action?

Cantor Fitzgerald upgraded Endo International (ENDP) to 'hold' from 'sell' and set a price target of $56.

Market News: Auxilium Pharmaceuticals, Advanced Micro Devices

Market News: Auxilium Pharmaceuticals, Advanced Micro Devices

ECB President Mario Draghi said there are signs of slowdown in the economic growth in the euro area and policy makers need to lift the excessively low level of inflationThe stock markets in the United...

Stock Market Today: S&P Suffers Worst Day in Six Months as Bears Invade

Stock Market Today: S&P Suffers Worst Day in Six Months as Bears Invade

The S&P 500 suffered its worst day in six months as Wall Street endured a broad-based selloff on eurozone fears.

Troubles Continue as Wet Seal Dips Nearly -20%

Troubles Continue as Wet Seal Dips Nearly -20%

Billionaire stock picks RadioShack Corporation (NYSE:RSH), LifeVantage Corp (NASDAQ:LFVN) and Auxilium Pharmaceuticals, Inc. (NASDAQ:AUXL) are killing it on the market today. In the red this Thursda...

Stock Market Today: Dow Unloads 300 Points in Broad-Based Selloff

Stock Market Today: Dow Unloads 300 Points in Broad-Based Selloff

Stock markets are sinking Thursday amid a continued slowdown in global growth.

How Endo International's $2.6B Deal for Auxilium Benefits Shareholders

How Endo International's $2.6B Deal for Auxilium Benefits Shareholders

With this deal for Auxilium, Endo has just turned itself into a top-tier global specialty health care leader.

Auxilium Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate The Buyout By Endo International

Auxilium Pharmaceuticals Shareholder Alert: Former SEC Attorney Willie Briscoe And Powers Taylor LLP Investigate The Buyout By Endo International

Former United States Securities and Exchange Commission attorney Willie Briscoe and the securities litigation firm of Powers Taylor LLP are investigating potential claims against the Board of Directors of Auxilium...

Stock Market Today: Gap Bombs; Traders Reverse Wednesday Rally

Stock Market Today: Gap Bombs; Traders Reverse Wednesday Rally

European Central Bank President Mario Draghi highlights a desperate need for reforms to revive the economies of the European Union.

Why Auxilium Pharmaceuticals (AUXL) Stock Hit a One-Year High Today

Why Auxilium Pharmaceuticals (AUXL) Stock Hit a One-Year High Today

Shares of Auxilium Pharmaceuticals (AUXL) hit a 52-week high Thursday after Endo International (ENDP) announced it would purchase the company in a cash-and-stock deal valued at approximately $2.6 billion.

Heavy Volume And Pre-Market Movement For Auxilium Pharmaceuticals (AUXL)

Heavy Volume And Pre-Market Movement For Auxilium Pharmaceuticals (AUXL)

Trade-Ideas LLC identified Auxilium Pharmaceuticals (AUXL) as a pre-market mover with heavy volume candidate

Endo Reaches Deal to Buy Auxilium Pharmaceuticals for $2.6B

Endo Reaches Deal to Buy Auxilium Pharmaceuticals for $2.6B

Endo International reaches a deal to buy Auxilium Pharmaceuticals for $33.25 a share in cash and stock.

Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion

Endo To Acquire Auxilium Pharmaceuticals In A Cash And Stock Transaction For Approximately $2.6 Billion

- Auxilium Shareholders to Receive $33.25 Per Share

Auxilium Pharma (AUXL) Upgraded From Sell to Hold

Auxilium Pharma (AUXL) Upgraded From Sell to Hold

Auxilium Pharma (AUXL) has been upgraded by TheStreet Ratings from Sell to Hold with a ratings score of C.

Stock Market Today: Stocks End Lower but Top Not Yet In Sight, Analysts Say

Stock Market Today: Stocks End Lower but Top Not Yet In Sight, Analysts Say

U.S. stocks close lower on Monday while strategists say the slide is just a temporary blip and predict the market still has more legs.

Stock Market Today: Stocks Fall as China Dampens Stimulus Hopes

Stock Market Today: Stocks Fall as China Dampens Stimulus Hopes

U.S. stock markets are down on Monday, as the Dow plunges with analysts saying this is not a market top.

How Will Auxilium Pharmaceuticals (AUXL) Stock React to FDA's Stendra Approval?

How Will Auxilium Pharmaceuticals (AUXL) Stock React to FDA's Stendra Approval?

Shares of Auxilium Pharmaceuticals (AUXL) were flat in morning trading Thursday despite the FDA's approval of the company's erectile dysfunction drug Stendra.